This project is a scientist-led molecular research initiative focused on understanding biological signals associated with endometriosis. The goal is to generate rigorous, reproducible evidence that can inform future diagnostic development, rather than relying on symptom-based assumptions or nonspecific inflammation markers.

No. This project does not offer a diagnostic test and is not intended for medical decision-making.

It is early-stage research designed to determine whether endometriosis-specific molecular signals can be reliably distinguished from general inflammation, which is a necessary prerequisite for any future diagnostic test.

The long-term goal is to support the future development and commercialization of a non-invasive diagnostic test, pending successful validation and regulatory review.

This research is currently in the early discovery and feasibility stage. At this phase, the focus is on evaluating whether disease-associated molecular patterns exist and can be measured consistently before any clinical claims or diagnostic applications are pursued.

Endometriosis is a complex, underdiagnosed condition that affects millions worldwide and often takes 7-10 years to diagnose. Despite this burden, diagnostic approaches remain largely invasive and symptom-driven. Endometriosis represents a clear case where improved biological understanding could meaningfully reduce diagnostic delays and patient harm.

While endometriosis is the initial focus, the underlying research approach may inform broader work in adenomyosis and related pelvic inflammatory conditions, where distinguishing disease-specific biology from background inflammation remains a major challenge.

Some tests on the market attempt to support endometriosis diagnosis by measuring general inflammation markers. However, inflammation is not specific to endometriosis and can be elevated in many unrelated conditions.

This research focuses on identifying the molecular signals more closely associated with endometriosis itself, addressing a key limitation of inflammation-based approaches.

For a deeper explanation of why reliable non-invasive tests for endometriosis remain challenging, see our overview on current testing and diagnosis limitations here.

Early-stage diagnostic research often falls into a funding gap, too applied for traditional academic grants, but too early for commercial investment. Crowdfunding enables independent, science-driven research to establish whether a viable diagnostic path exists before clinical claims are made.

Funds will support molecular analysis, bioinformatics, sample access, and research infrastructure required to conduct early-stage feasibility studies. All work is focused on generating high-quality evidence.

Yes. Research progress, milestones, and high-level findings will be shared publicly where appropriate, while respecting ethical, legal, and scientific integrity requirements.

The total funding required depends on research outcomes at each stage. This campaign supports early feasibility work, which determines whether further validation and diagnostic development are scientifically justified.